{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T07:57:50Z","timestamp":1768291070790,"version":"3.49.0"},"reference-count":17,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (FCT)","award":["2022.05718.PTDC"],"award-info":[{"award-number":["2022.05718.PTDC"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Natural products, characterized by huge scaffold diversity, complexity, and bioactivity, have long played a crucial role in drug discovery and development, particularly as anticancer and anti-infective agents [...]<\/jats:p>","DOI":"10.3390\/ijms241814321","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T21:26:32Z","timestamp":1695245192000},"page":"14321","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Natural Product-Derived Compounds for Targeting Multidrug Resistance in Cancer and Microorganisms"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8742-1486","authenticated-orcid":false,"given":"Maria-Jos\u00e9","family":"U. Ferreira","sequence":"first","affiliation":[{"name":"Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Gama Pinto, 1649-003 Lisbon, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.biotechadv.2015.08.001","article-title":"Discovery and resupply of pharmacologically active plant-derived natural products: A review","volume":"33","author":"Atanasov","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Paterson","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.phymed.2008.06.008","article-title":"Synergism between natural products and antibiotics against infectious diseases","volume":"15","author":"Hemaiswarya","year":"2008","journal-title":"Phytomedicine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ejmech.2019.05.027","article-title":"Natural products as multidrug resistance modulators in cancer","volume":"176","author":"Kumar","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrmicro3380","article-title":"Molecular mechanisms of antibiotic resistance","volume":"13","author":"Blair","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"100110","DOI":"10.1016\/j.crphar.2022.100110","article-title":"Evaluation of synergism in drug combinations and reference models for future orientations in oncology","volume":"3","author":"Duarte","year":"2022","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"204ra132","DOI":"10.1126\/scitranslmed.3006609","article-title":"Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development","volume":"5","author":"Imamovic","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.tips.2009.07.003","article-title":"Is resistance useless? Multidrug resistance and collateral sensitivity","volume":"30","author":"Hall","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Sch\u00e4fer, J., Kl\u00f6sgen, V.J., Omer, E.A., Kadioglu, O., Mbaveng, A.T., Kuete, V., Hildebrandt, A., and Efferth, T. (2023). In Silico and In Vitro Identification of P-Glycoprotein Inhibitors from a Library of 375 Phytochemicals. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241210240"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Sun, W., Wong, I.L.K., Law, H.K.W., Su, X., Chan, T.C.F., Sun, G., Yang, X., Wang, X., Chan, T.H., and Wan, S. (2023). In Vivo Reversal of P-Glycoprotein-Mediated Drug Resistance in a Breast Cancer Xenograft and in Leukemia Models Using a Novel, Potent, and Nontoxic Epicatechin EC31. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054377"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1021\/acs.jmedchem.5b00085","article-title":"Potent and Nontoxic Chemosensitizer of P-Glycoprotein-Mediated Multidrug Resistance in Cancer: Synthesis and Evaluation of Methylated Epigallocatechin, Gallocatechin, and Dihydromyricetin Derivatives","volume":"58","author":"Wong","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"113795","DOI":"10.1016\/j.ejmech.2021.113795","article-title":"Synthesis and evaluation of stereoisomers of methylated catechin and epigallocatechin derivatives on modulating P-glycoprotein-mediated multidrug resistance in cancers","volume":"226","author":"Wong","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Sancha, S.A.R., Szemer\u00e9di, N., Spengler, G., and Ferreira, M.J.U. (2023). Lycorine Carbamate Derivatives for Reversing P-glycoprotein-Mediated Multidrug Resistance in Human Colon Adenocarcinoma Cells. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032061"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Sancha, S.A.R., Gomes, A.V., Loureiro, J.B., Saraiva, L., and Ferreira, M.J.U. (2022). Amaryllidaceae-Type Alkaloids from Pancratium maritimum: Apoptosis-Inducing Effect and Cell Cycle Arrest on Triple-Negative Breast Cancer Cells. Molecules, 27.","DOI":"10.3390\/molecules27185759"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Wu, M.F., Huang, Y.H., Chiu, L.Y., Cherng, S.H., Sheu, G.T., and Yang, T.Y. (2022). Curcumin Induces Apoptosis of Chemoresistant Lung Cancer Cells via ROS-Regulated p38 MAPK Phosphorylation. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158248"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Jia, F., Yu, Q., Wang, R., Zhao, L., Yuan, F., Guo, H., Shen, Y., and He, F. (2023). Optimized Antimicrobial Peptide Jelleine-I Derivative Br-J-I Inhibits Fusobacterium nucleatum to Suppress Colorectal Cancer Progression. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021469"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Liu, S., Hon, K., Bouras, G.S., Psaltis, A.J., Shearwin, K., Wormald, P.J., and Vreugde, S. (2022). APTC-C-SA01: A Novel Bacteriophage Cocktail Targeting Staphylococcus aureus and MRSA Biofilms. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23116116"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/18\/14321\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:54:13Z","timestamp":1760129653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/18\/14321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,20]]},"references-count":17,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["ijms241814321"],"URL":"https:\/\/doi.org\/10.3390\/ijms241814321","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,20]]}}}